| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d037bc74e34c7d73dd883f208aef0518 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-816 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 |
| filingDate |
1995-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53a4ad9a2ca3c0663792494dac379a3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_008869e4ae61ba2deee8d5afeaf22c97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_983acc28688655f8c795b2f05dab1de1 |
| publicationDate |
1998-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0753152-B1 |
| titleOfInvention |
Solid phase immunoassay to detect inhibitors of proteolytic enzymes |
| abstract |
PCT No. PCT/EP95/00867 Sec. 371 Date Sep. 23, 1996 Sec. 102(e) Date Sep. 23, 1996 PCT Filed Mar. 9, 1995 PCT Pub. No. WO95/26505 PCT Pub. Date Oct. 5, 1995Solid phase immunoassay for detecting specific inhibitors of proteolytic enzymes in biological fluids, which comprises: a) contacting a tubulin peptide covalently linked to a support with a solution containing a proteolytic activity together with a protease inhibitor, b) detecting the inhibitor activity against the selected proteases by contacting the support with a solution containing a labelled monoclonal antibody which specifically recognises the free end of the tubulin peptide linked to the support. |
| priorityDate |
1994-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |